Johanniskraut Sidroga

Hypericum perforatum, the active ingredient in Johanniskraut Sidroga, is a herbal medicine presented as an unspecified/oral form for oral use. It is used to support mood in adults with mild to moderate depression and seasonal affective disorder.

GNH USA supplies Johanniskraut Sidroga as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Johanniskraut Sidroga is an herbal antidepressant that acts on mood‑regulating pathways. - Mild to moderate depression: helps alleviate depressive symptoms in adults. - Seasonal affective disorder: reduces mood swings associated with seasonal changes. - Adjunctive mood support: can be used alongside other therapies to improve overall emotional wellbeing.

Hypericum perforatum may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Gastrointestinal upset: nausea, stomach discomfort, or diarrhoea. - Skin reactions: photosensitivity leading to sunburn‑like symptoms. - Dizziness or headache. - Fatigue or mild drowsiness. - Dry mouth.

Serious or Rare Side Effects: - Serotonin syndrome when combined with other serotonergic agents. - Severe allergic reactions such as rash, itching, or swelling. - Hepatic enzyme induction leading to reduced efficacy of concurrent medications. - Mood worsening or emergence of suicidal thoughts in rare cases.

When considering Johanniskraut Sidroga, several safety measures should be observed. - Contraindication: avoid use in patients taking monoamine oxidase inhibitors or other serotonergic drugs. - Pregnancy and breastfeeding: safety has not been established; consult a healthcare professional. - Phototoxicity: advise patients to limit excessive sun exposure and use sunscreen. - Drug interactions: review all concomitant medications for potential interactions. - Monitoring: assess mood changes regularly, especially during the initial treatment period. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Hypericum perforatum can affect the metabolism of several drugs, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome. - Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: heightened serotonin toxicity. - Warfarin: may reduce anticoagulant effect, increasing clot risk.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower hormonal efficacy, leading to unintended pregnancy. - Cyclosporine and tacrolimus: possible reduction in immunosuppressant levels. - Antiretrovirals (e.g., protease inhibitors): may decrease plasma concentrations. - Anticonvulsants (e.g., carbamazepine): potential for reduced seizure control.